Skip to content
Search the site

Clinical trial NCT04075435

Status: Active, not recruitingEarly phase 1Latest change: Source: ClinicalTrials.gov

What's on this page?

Information in the record

Original title: Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

Record number
NCT04075435
Status
Active, not recruiting
Type and phase
Clinical trial, early phase 1
Participants
Target: 12
Condition (as registered)
Alzheimer Disease, Anxiety, Agitation,Psychomotor, Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Countries
United States
Topic in the guide
Anxiety, Dementia

Timeline

According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.

  • Start: January 11, 2021
  • End of data collection for primary results: December 2026 (expected)
  • Trial completion: December 2026 (expected)

History

We check the record every day; here are the changes we have seen since we started tracking it, newest first.

  • : Added to tracking. Status: Active, not recruiting.

Results

No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.

All ongoing trials · Anxiety: ongoing trials · Dementia: ongoing trials · Thinking of taking part? Which specialist to see